Complement blockade for TA-TMA: Lessons learned from a large pediatric cohort treated with eculizumab.
Jodele, S; Dandoy, CE; Lane, A; Laskin, BL; Laskin, B; Teusink-Cross, A; Myers, KC; Wallace, G; Nelson, AS; Nelson, A; et al.
Blood.
2020;
26:S138-S138.
Interferon-complement loop in transplant-associated thrombotic microangiopathy.
Jodele, S; Medvedovic, M; Luebbering, N; Chen, J; Dandoy, CE; Laskin, BL; Davies, SM.
Blood Advances.
2020;
4:1166-1177.
High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma.
Jodele, S; Dandoy, CE; Myers, K; Wallace, G; Lane, A; Teusink-Cross, A; Weiss, B; Davies, SM.
Bone Marrow Transplantation.
2018;
53:1311-1318.
Terminal Complement Blockade after Hematopoietic Stem Cell Transplantation Is Safe without Meningococcal Vaccination.
Jodele, S; Dandoy, CE; Danziger-Isakov, L; Myers, KC; El-Bietar, J; Nelson, A; Wallace, G; Teusink-Cross, A; Davies, SM.
Biology of Blood and Marrow Transplantation.
2016;
22:1337-1340.
New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Jodele, S; Dandoy, CE; Myers, KC; El-Bietar, J; Nelson, A; Wallace, G; Laskin, BL.
Transfusion and Apheresis Science.
2016;
54:181-190.
The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy.
Jodele, S; Zhang, K; Zou, F; Laskin, B; Dandoy, CE; Myers, KC; Lane, A; Meller, J; Medvedovic, M; Chen, J; et al.
Blood.
2016;
127:989-996.
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.
Jodele, S; Fukuda, T; Mizuno, K; Vinks, AA; Laskin, BL; Goebel, J; Dixon, BP; Chima, RS; Hirsch, R; Teusink, A; et al.
Biology of Blood and Marrow Transplantation.
2016;
22:307-315.
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults.
Jodele, S; Davies, SM; Lane, A; Khoury, J; Dandoy, C; Goebel, J; Myers, K; Grimley, M; Bleesing, J; El-Bietar, J; et al.
Blood.
2014;
124:645-653.
Eculizumab Therapy in Children with Severe Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy.
Jodele, S; Fukuda, T; Vinks, A; Mizuno, K; Laskin, BL; Goebel, J; Dixon, BP; Teusink, A; Pluthero, FG; Lu, L; et al.
Biology of Blood and Marrow Transplantation.
2014;
20:518-525.
Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Jodele, S; Licht, C; Goebel, J; Dixon, BP; Zhang, K; Sivakumaran, TA; Davies, SM; Pluthero, FG; Lu, L; Laskin, BL.
Blood.
2013;
122:2003-2007.